AnalystsMarc Frahm
Marc Frahm's Stock Forecasts

Sectors:

Healthcare

Industries:

Biotechnology

Analyst Ranking

Bottom 9%

#4462 out of 4870 analysts

Average Return

-36.23%

Win Rate

8%1 out of 12

Risk vs Reward

Poor

Good

Marc Frahm's 5 best and worst ratings

Name / Ticker	Gain/Loss	Entry Price	Exit Price	Period	Rating
Incyte CorpINCY	+18.36%	$52.94	$62.66	2024-05-01 - 2025-04-30	Strong Buy

Marc Frahm Analyst Color

Get additional color on Marc Frahm's coverage of popular stocks

Marc Frahm's Stock Coverage

Name / Ticker	No. Ratings	Rating	Price Target	Upside/Downside	Action	Date
Theravance Biopharma IncTBPH	2	Hold	$9.00	-13.38%	Maintains	9 months ago
Incyte CorpINCY	3	Strong Buy	$80.00	N/A	Maintains	a year ago
Imago Biosciences IncIMGO	2	Hold	$36.00	N/A	Downgrades	2 years ago
Xilio Therapeutics IncXLO	1	Buy	N/A	N/A	Initiates Coverage On	3 years ago
Nuvalent IncNUVL	1	Buy	N/A	N/A	Initiates Coverage On	4 years ago
Elevation Oncology IncELEV	1	Buy	N/A	N/A	Initiates Coverage On	4 years ago
Janux Therapeutics IncJANX	1	Buy	N/A	N/A	Initiates Coverage On	4 years ago
Day One Biopharmaceuticals IncDAWN	1	Buy	N/A	N/A	Initiates Coverage On	4 years ago
Constellation Pharmaceuticals IncCNST	2	Hold	N/A	N/A	Downgrades	4 years ago
Inozyme Pharma IncINZY	1	Buy	N/A	N/A	Initiates Coverage On	5 years ago
Black Diamond Therapeutics IncBDTX	1	Buy	N/A	N/A	Initiates Coverage On	5 years ago

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.